MARCO GOTTARDIS, PH.D.
PROSTATE CANCER DISEASE AREA STRONGHOLD LEADER FOR THE ONCOLOGY THERAPEUTIC AREA
Marco Gottardis, Ph.D. is Vice President and Prostate Cancer Disease Area Stronghold Leader for the Oncology Therapeutic Area at Janssen Research & Development, LLC. In this role, he is responsible for maintaining and enhancing Janssen’s leadership in driving the strategy to discover and develop new therapeutics to treat and prevent prostate cancer.
Marco was an established leader in Oncology Discovery Research at Bristol-Myers Squibb (BMS) for 14 years with achievements spanning exploratory research to Investigational New Drug (IND) candidates. He led multiple scientific teams at BMS covering diverse target areas. He was a member of the Disease Sciences and Biologics Senior Leadership Team and served on the Oncology Early Development and Commercial Strategic Teams for Prostate and Melanoma. Marco has placed multiple discovery candidates into development and has successfully led Early Development Asset Teams that were responsible for progressing development candidates from IND to Phase 2 Proof of Concept.
Marco has 20 years of experience as a cancer research investigator in both biotech/large pharma and over 25 years’ experience in overall translational cancer research. He has had a role in the development of several drug approvals in his career. These include the seminal pre-clinical studies leading to the development of a treatment for breast cancer and the approval of selective estrogen receptor modulator, retinoid and retinoid X receptor drugs for cancer while he was a Senior Investigator at Ligand Pharmaceuticals, Inc., San Diego, California.